Meeting the needs of rare disease patients: Improved access to specialty pharmaceuticals, gene and cell therapies

· 5 min read

Specialty carve outs that move specialty drugs away from traditional prescription drug management to a pharmacy benefit administrator (PBA) or specialty administrator will continue and likely to provide cost savings.

To read the full article, click here.

Cookie Policy

Read our Privacy Policy to learn more.